10:25 AM EDT, 09/10/2024 (MT Newswires) -- Guardant Health ( GH ) said Tuesday that it partnered with the Agostino Gemelli University Polyclinic Foundation IRCCS, or Policlinico Gemelli, in Italy to establish the hospital's in-house liquid biopsy testing service.

The liquid biopsy testing service will be a part of the diagnostics services under Policlinico Gemelli's hospital system and will use Guardant Health's ( GH ) proprietary digital sequencing platform, according to the statement. No financial terms were disclosed.

Price: 24.00, Change: +0.23, Percent Change: +0.97